Caption Management, LLC Arvinas, Inc. Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $3.4 Million - $4.71 Million	143,900 New	143,900 $3.54 Million
Q1 2022 May 13, 2022	BUY	$60.27 - $81.57 $1.51 Million - $2.04 Million	25,000 New	25,000 $1.68 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $3.02 Million - $4.21 Million	-50,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $1.02 Million - $1.6 Million	-17,500 Reduced 25.93%	50,000 $3.3 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $20,190 - $84,930	1,000 Added 1.5%	67,500 $5.73 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $1.99 Million - $3.77 Million	66,500 New	66,500 $2.23 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $997M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.